N-甲基-D-天冬氨酸(NMDA)受体介导瘦素信号传导并调节胰腺β细胞中的钾通道转运。

NMDA receptors mediate leptin signaling and regulate potassium channel trafficking in pancreatic β-cells.

作者信息

Wu Yi, Fortin Dale A, Cochrane Veronica A, Chen Pei-Chun, Shyng Show-Ling

机构信息

From the Department of Biochemistry and Molecular Biology, Oregon Health and Science University, Portland, Oregon 97239 and.

the Department of Physiology, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan

出版信息

J Biol Chem. 2017 Sep 15;292(37):15512-15524. doi: 10.1074/jbc.M117.802249. Epub 2017 Aug 2.

Abstract

NMDA receptors (NMDARs) are Ca-permeant, ligand-gated ion channels activated by the excitatory neurotransmitter glutamate and have well-characterized roles in the nervous system. The expression and function of NMDARs in pancreatic β-cells, by contrast, are poorly understood. Here, we report a novel function of NMDARs in β-cells. Using a combination of biochemistry, electrophysiology, and imaging techniques, we now show that NMDARs have a key role in mediating the effect of leptin to modulate β-cell electrical activity by promoting AMP-activated protein kinase (AMPK)-dependent trafficking of K and Kv2.1 channels to the plasma membrane. Blocking NMDAR activity inhibited the ability of leptin to activate AMPK, induce K and Kv2.1 channel trafficking, and promote membrane hyperpolarization. Conversely, activation of NMDARs mimicked the effect of leptin, causing Ca influx, AMPK activation, and increased trafficking of K and Kv2.1 channels to the plasma membrane, and triggered membrane hyperpolarization. Moreover, leptin potentiated NMDAR currents and triggered NMDAR-dependent Ca influx. Importantly, NMDAR-mediated signaling was observed in rat insulinoma 832/13 cells and in human β-cells, indicating that this pathway is conserved across species. The ability of NMDARs to regulate potassium channel surface expression and thus, β-cell excitability provides mechanistic insight into the recently reported insulinotropic effects of NMDAR antagonists and therefore highlights the therapeutic potential of these drugs in managing type 2 diabetes.

摘要

N-甲基-D-天冬氨酸受体(NMDARs)是钙通透的配体门控离子通道,由兴奋性神经递质谷氨酸激活,在神经系统中具有明确的作用。相比之下,NMDARs在胰腺β细胞中的表达和功能却知之甚少。在此,我们报告了NMDARs在β细胞中的一种新功能。通过结合生物化学、电生理学和成像技术,我们现在表明,NMDARs在介导瘦素通过促进AMP激活的蛋白激酶(AMPK)依赖的钾通道和Kv2.1通道向质膜转运来调节β细胞电活动的作用中起关键作用。阻断NMDAR活性会抑制瘦素激活AMPK、诱导钾通道和Kv2.1通道转运以及促进膜超极化的能力。相反,NMDARs的激活模拟了瘦素的作用,导致钙内流、AMPK激活以及钾通道和Kv2.1通道向质膜的转运增加,并引发膜超极化。此外,瘦素增强了NMDAR电流并触发了NMDAR依赖的钙内流。重要的是,在大鼠胰岛素瘤832/13细胞和人β细胞中观察到了NMDAR介导的信号传导,表明该途径在物种间是保守的。NMDARs调节钾通道表面表达从而调节β细胞兴奋性的能力,为最近报道的NMDAR拮抗剂的促胰岛素作用提供了机制上的见解,因此突出了这些药物在治疗2型糖尿病方面的潜在治疗价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索